Researchers at Queen Mary University of London and University of Cambridge in collaboration with colleagues at HHMI Janelia and NIH, have created some of the most detailed three-dimensional maps ever ...

Featuring Thermo Fisher Scientific, Agilent Technologies, Merck, Eurofins Scientific, Charles River Labs and Other Key ...

Tuberculosis meningitis treatment may be approaching a turning point: a Cincinnati Children’s-led study in Nature Communications finds semaglutide — the diabetes drug sold as Ozempic — outperforms ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced its first commercial sales in ...

Patient-derived organoids contribute to precision medicine by enabling direct drug testing on a patient’s tumor. These models ...

Researchers from UTS and Monash University have identified vitronectin as a key protein driving abnormal lung scarring in ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced revenue ...

ARPA-H gene editing program THRIVE awards $160 million to seven research teams tasked with building scalable base-editing ...

Auxilium says it bioprinted kidney and liver tissue on the ISS, a first. The near-term payoff is drug-testing organoids, not transplant organs.

Creative Biolabs is proud to announce an upcoming industry webinar on engineered human 3D brain tissues for neurodegenerative disease modeling.

Tesla hasn't improved much on the performance of its 4680 cells, which it now uses in some Model Y variants, including Long Range models built at Giga Berlin. The switch was made quietly, leading to a ...

The Tesla Model 3 Premium RWD introduced in Canada is likely powered by new LFP cells produced by Sunwoda. These feature superior characteristics compared to previous CATL cells, including a 4C ...